Bandingkan Harga & Kinerja Asuransi Jiwa Syariah Jasa Mitra Abadi Tbk. (JMAS) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Asuransi Jiwa Syariah Jasa Mitra Abadi Tbk. dan Organon Pharma Indonesia Tbk.: Asuransi Jiwa Syariah Jasa Mitra Abadi Tbk. diperdagangkan di Rp228 (kapitalisasi pasar 228 M), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Asuransi Jiwa Syariah Jasa Mitra Abadi Tbk. jauh lebih besar — sekitar 2,2× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| JMAS | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 228 M | 104,4 M |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Asuransi Jiwa Syariah Jasa Mitra Abadi Tbk.
PT Asuransi Jiwa Syariah Jasa Mitra Abadi Tbk (the Company) was established under the laws and regulations of the law Republic of Indonesia originally under the name "PT Jasa Mitra Abadi", domiciled in South Jakarta based on Notarial Deed No. 22 dated August 15, 2014, by Rosida Rajagukguk Siregar, Bachelor of Law, Master of Notary, Notary in South Jakarta.
Selengkapnya di halaman JMAS →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
